Oral, Oropharyngeal & Salivary Gland Cancers | National Institute of Dental and Craniofacial Research

Skip to main content

Oral, Oropharyngeal & Salivary Gland Cancers

The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)

PAR-18-830

Development of Novel and Robust Systems for Mechanistic Studies of Gene-Environment Interplay in Dental, Oral, Craniofacial, and Other Diseases and Conditions (R21 Clinical Trial Not Allowed)

PAR-19-293

Mechanistic Studies of Gene-Environment Interplay in Dental, Oral, Craniofacial, and Other Diseases and Conditions (R01 Clinical Trial Not Allowed)

PAR-19-292

Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed)

PAR-19-194

Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed)

PAR-19-193

Advancing Cancer Immunotherapy by Mitigating Immune-related Adverse Events (irAEs) (U01 Clinical Trial Not Allowed)

RFA-CA-19-044

Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed)

PAR-19-173

Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed)

PAR-19-172

Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed)

RFA-CA-19-015

Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed)

RFA-CA-19-014